{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rheumatoid+Arthritis+-+Rheumatism", "query": { "condition": "Rheumatoid Arthritis - Rheumatism" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 1092, "total_pages": 110, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rheumatoid+Arthritis+-+Rheumatism&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T21:46:40.507Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06544642", "title": "A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Sjögren's Syndrome" ], "interventions": [ { "name": "ASP5502", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Global Development, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 116, "start_date": "2024-08-21", "completion_date": "2026-03-05", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "Daytona Beach, Florida", "locations": [ { "city": "Daytona Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06544642" }, { "nct_id": "NCT00595413", "title": "Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Placebo matched to atacicept", "type": "DRUG" }, { "name": "Atacicept: with loading dose", "type": "DRUG" }, { "name": "Atacicept", "type": "DRUG" }, { "name": "Adalimumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 311, "start_date": "2007-09", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2016-02-17", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "Rockland, Massachusetts", "locations": [ { "city": "Rockland", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00595413" }, { "nct_id": "NCT02780388", "title": "A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Adult Onset Rheumatoid Arthritis" ], "interventions": [ { "name": "VIB4920", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 57, "start_date": "2016-05-12", "completion_date": "2018-08-09", "has_results": true, "last_update_posted_date": "2024-12-27", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 8, "location_summary": "Anniston, Alabama • DeBary, Florida • Jacksonville, Florida + 5 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "DeBary", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02780388" }, { "nct_id": "NCT02920346", "title": "Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sjogren's Syndrome", "Neonatal Systemic Lupus Erythematosus", "Fetal Heart Block Complete" ], "interventions": [], "intervention_types": [], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 700, "start_date": "2014-03", "completion_date": "2020-06-16", "has_results": false, "last_update_posted_date": "2021-06-23", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02920346" }, { "nct_id": "NCT04751396", "title": "Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ankylosing Spondylitis", "Autoimmune Disease", "Crohn Disease", "Enteropathic Arthritis", "Enteropathic Spondylitis", "Inflammatory Bowel Disease", "Melanoma", "Psoriasis", "Psoriatic Arthritis", "Reactive Arthritis", "Rheumatoid Arthritis", "Systemic Lupus Erythematosus", "Ulcerative Colitis" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2022-04-20", "completion_date": "2027-02-02", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04751396" }, { "nct_id": "NCT05398471", "title": "Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [], "intervention_types": [], "sponsor": "Power Life Sciences Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2024-08", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2024-01-02", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05398471" }, { "nct_id": "NCT04649177", "title": "Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Keratoconus", "Ocular Surface Disease", "Pellucid Marginal Corneal Degeneration", "Ectasia", "Corneal Trauma", "Corneal Scar", "Dry Eye Syndromes", "Keratoconjunctivitis Sicca", "Sjogren's Syndrome" ], "interventions": [ { "name": "Ocular surface optical coherence tomography", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Sight", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 11, "start_date": "2020-12-15", "completion_date": "2022-03-23", "has_results": true, "last_update_posted_date": "2023-10-27", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "Needham, Massachusetts", "locations": [ { "city": "Needham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04649177" }, { "nct_id": "NCT01647737", "title": "Green Tea Lozenges for the Management of Dry Mouth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Xerostomia", "Sjogren Syndrome", "Dry Mouth" ], "interventions": [ { "name": "MighTeaFlow", "type": "DIETARY_SUPPLEMENT" }, { "name": "Xylitol", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Augusta University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2011-03", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2015-03-18", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "Augusta, Georgia", "locations": [ { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01647737" }, { "nct_id": "NCT00782600", "title": "Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "suspension IR", "type": "DRUG" }, { "name": "CR 1", "type": "DRUG" }, { "name": "CR 2", "type": "DRUG" }, { "name": "CR 3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 16, "start_date": "2008-07", "completion_date": "2008-08", "has_results": false, "last_update_posted_date": "2009-06-09", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00782600" }, { "nct_id": "NCT06880653", "title": "Dose Response of Exercise for Arthritis Management", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Arthritis", "Rheumatoid Arthritis (RA)", "Gout", "Fibromyalgia (FM)", "Osteoarthritis", "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "DREAM Adaptive Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 285, "start_date": "2025-03-28", "completion_date": "2029-04-30", "has_results": false, "last_update_posted_date": "2026-04-03", "last_synced_at": "2026-09-24T21:46:40.507Z", "location_count": 1, "location_summary": "Columbia, South Carolina", "locations": [ { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06880653" } ] }